id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263422-ojdcag0r	Aranda-Abreu, Gonzalo Emiliano	Response to: Amantadine, COVID-19 and Parkinsonism	2020-07-20		.txt	text/plain	130	15	73	key: cord-263422-ojdcag0r authors: Aranda-Abreu, Gonzalo Emiliano title: Response to: Amantadine, COVID-19 and Parkinsonism date: 2020-07-20 journal: Arch Med Res DOI: 10.1016/j.arcmed.2020.07.002 sha: doc_id: 263422 cord_uid: ojdcag0r nan The fact that Parkinson's patients get COVID-19 is probably because their main medication was Levodopa and not amantadine. I would like to point out that amantadine is an antiviral that is able to mitigate the effects of COVIDPhenomenology and outcomes of in-patients with Parkinson's disease during COVID-19 pandemic Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study Amantadine as a drug to mitigate the effects of COVID-19 Amantadine Treatment for People with COVID-19 Use of amantadine in a patient with SARS-CoV-2 Online ahead of print Online ahead of print	./cache/cord-263422-ojdcag0r.txt	./txt/cord-263422-ojdcag0r.txt